Since mitochondrial impairment and oxidative stress are well known elements in the pathophysiology of epilepsy and depression [4, 33, 58], we hypothesized that modulation of this oxidative stress and restitution of mitochondrial function was how NI enabled activation of the ERK/CREB/BDNF signaling pathway. The gene discussed is MAPK1; the disease is depressive symptom measurement.